financetom
Business
financetom
/
Business
/
This 27-year-old from London built a $7.8-billion business after a rare allergic reaction
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
This 27-year-old from London built a $7.8-billion business after a rare allergic reaction
Aug 17, 2021 11:47 AM

Sweet are the uses of adversity for some. Johnny Boufarhat had a rare allergic reaction in 2015 which left him with a misfiring immune system. Little did he know that it would make him a billionaire a few years later.

Share Market Live

NSE

Due to his condition, Boufarhat was forced to stay inside. In 2019, he wrote a code in frustration for an online events platform called Hopin Ltd while sitting in his London apartment kitchen.

Early this month, Hopin raised $450 million from investors, including Brad Gerstner's Altimeter Capital Management, valuing Hopin at $7.8 billion.

The 27-year-old is now among the world's youngest self-made billionaires at $3.2 billion, according to the Bloomberg Billionaires Index.

When first released, Hopin allowed users to attend break-out sessions during events and network with attendees through automated one-on-one video meetings. Though Boufarhat had initially planned to launch Hopin in September 2020, the pandemic forced him to speed up his release date by six months and catapulted his fortunes, with people shifting to online meetings after lockdowns were announced.

Hopin has come a long way. They now employ 800 people, up from the six in 2020, have bought out video tech companies like StreamYard, Streamable and Jamm. In June, they acquired Boomset, a management platform for in-person and hybrid events and in July, they acquired event marketing company, Attendify.

He has an incredible passion for business and a clear vision, said Tom Wilson of Seedcamp, who led Hopin’s 2019 pre-seed investment round to Bloomberg.

"Johnny had it figured out long before the pandemic," said Par-Jorgen Parson, general partner, Northzone. Northzone is a London-based venture capital firm and one of Hopin’s backers.

According to Bloomberg’s Billionaire index, there are 19 billionaires under the age of 40 in the world’s 500 richest list and Boufarhat is the latest to join the club. He joins the likes of Patrick and John Collision, who founded online payment company Stripe; Nikolay Storonsky, founder of Revolut and Luminar Technologies; and Austin Russel, who is all of 26 years.

(Edited by : Shoma Bhattacharjee)

First Published:Aug 17, 2021 8:47 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ukraine receives first F-16 jets, officials say
Ukraine receives first F-16 jets, officials say
Jul 31, 2024
July 31 (Reuters) - The first batch of long-awaited F-16 jets have arrived in Ukraine, Lithuania's foreign minister and a U.S. official said on Wednesday, an effort Kyiv has said will help rebuild its depleted air force. F-16s, built by Lockheed Martin ( LMT ), have been on Ukraine's wish list for a long time because of their destructive power...
FMC Q2 Adjusted Earnings, Revenue Rise; Q3 Outlook Set; 2024 Guidance Revised -- Shares Jump After Hours
FMC Q2 Adjusted Earnings, Revenue Rise; Q3 Outlook Set; 2024 Guidance Revised -- Shares Jump After Hours
Jul 31, 2024
05:59 PM EDT, 07/31/2024 (MT Newswires) -- FMC (FMC) reported Q2 adjusted earnings late Wednesday of $0.63 per diluted share, up from $0.50 a year earlier. Analysts polled by Capital IQ expected $0.55. Revenue for the quarter ended June 30 was $1.04 billion, up from $1.01 billion a year earlier. Analysts surveyed by Capital IQ expected $1.03 billion. The company...
Jazz Pharmaceuticals Q2 Non-GAAP Earnings, Revenue Rise, 2024 Outlook Updated
Jazz Pharmaceuticals Q2 Non-GAAP Earnings, Revenue Rise, 2024 Outlook Updated
Jul 31, 2024
05:58 PM EDT, 07/31/2024 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) late Wednesday reported Q2 non-GAAP net income of $5.30 per diluted share, up from $4.51 a year earlier. Analysts polled by Capital IQ expected $4.77. Revenue for the quarter ended June 30 was $1.02 billion, compared with $957.3 million a year earlier. Analysts expected $1 billion. For 2024,...
Host Hotels & Resorts Q2 Adjusted FFO, Revenue Increase; Lowers 2024 Adjusted FFO Outlook; Buys 1 Hotel Central Park
Host Hotels & Resorts Q2 Adjusted FFO, Revenue Increase; Lowers 2024 Adjusted FFO Outlook; Buys 1 Hotel Central Park
Jul 31, 2024
05:19 PM EDT, 07/31/2024 (MT Newswires) -- Host Hotels & Resorts ( HST ) reported Q2 adjusted funds from operations Wednesday of $0.57 per diluted share, up from $0.53 a year earlier. Analysts polled by Capital IQ expected $0.43. Revenue for the quarter ended June 30 was $1.47 billion, up from $1.39 billion a year earlier. Analysts surveyed by Capital...
Copyright 2023-2026 - www.financetom.com All Rights Reserved